Prostatic stromal tumour of uncertain malignant potential in a dog
View abstract on PubMed
Summary
This summary is machine-generated.A prostatic stromal tumor of uncertain malignant potential was diagnosed in a Miniature Dachshund presenting with dyschezia. Surgical removal was performed, and the tumor showed atypical stromal cells with specific immunohistochemical markers.
Area Of Science
- Veterinary Pathology
- Canine Oncology
- Surgical Oncology
Background
- Dyschezia in dogs can indicate various underlying conditions, including prostatic diseases.
- Prostatic tumors, though less common than other canine neoplasms, require accurate diagnosis and characterization.
Observation
- An 11-year-old Miniature Dachshund presented with dyschezia, leading to the discovery of a significant prostate mass via computed tomography.
- Surgical intervention, including prostatectomy and orchiectomy, was performed. Gross examination revealed a demarcated, rubbery, whitish mass.
- Microscopic analysis showed a capsulated tumor with atypical spindloid stromal cells in phyllode and fasciculated patterns, admixed with ductal cells.
Findings
- Immunohistochemical analysis of the atypical stromal cells revealed positivity for vimentin, CD34, desmin, alpha-smooth muscle actin, progesterone receptor, and androgen receptor.
- The stromal cells were negative for cytokeratin AE1/AE3, p63, c-Kit, DOG-1, and SOX10.
- The combination of morphological and immunohistochemical features led to the diagnosis of a prostatic stromal tumor of uncertain malignant potential.
Implications
- This case highlights the importance of comprehensive diagnostic approaches, including advanced imaging and immunohistochemistry, for accurate characterization of canine prostatic tumors.
- The diagnosis of 'uncertain malignant potential' underscores the need for careful monitoring and further research into the behavior and prognosis of such tumors in dogs.
- Understanding the specific immunohistochemical profile aids in differentiating prostatic stromal tumors from other prostatic neoplasms and informs potential therapeutic strategies.

